Skip to content

FBIOP

Fortress Biotech, Inc.

NASDAQ · Healthcare · Biotechnology · US

$16.70
+0.17%
Ask drillr

Year over year

Reported trailing growth

Revenue
+15.5%
EBITDA
+321.3%
EBIT
+72.9%
EPS
+394.8%
Free cash flow
+257.1%
Operating cash flow
+257.2%

Forward estimates

Based on analyst estimates

Revenue
-67.2%
EBITDA
—
EPS
—

Three-year CAGR

Revenue
-5.8%
EBITDA
+80.7%
EBIT
+36.4%
Net income
+114.8%
EPS
+97.5%
Free cash flow
+30.9%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026